Evaluation of Antenatal Maternal Serum Biomarkers in Pregnancies Over 41 Weeks

Authors

  • Hatice Kansu Çelik Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Yaprak Engin Üstün Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Hakan Timur Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Selan Yaman Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Saynur Yılmaz Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Elif Gül Yapar Eyı Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara
  • Leyla Mollamahmutoğlu Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara

Keywords:

Post-term pregnancy, Maternal serum screening

Abstract

OBJECTIVE: To examine association between maternal antenatal serum biomarkers and post-term pregnancies.
STUDY DESIGN: Singleton pregnant women (n=186) managed at the Zekai Tahir Burak Women’s Health, Education and Research Hospital in Turkey from July 2010 to December 2010 were analyzed retrospectively. Maternal serum levels of PAPP-A, free β-hCG, AFP, HCG and unconjugated E3 were noted routinely in antenatal screening programs. We compared these biomarkers in pregnancies between 37 and 41 gestational weeks (n=73) and ≥41 (n=113) gestational weeks.
RESULTS: There was no statistically significant difference in maternal PAPP-A, free beta-hCG, AFP, total hCG and unconjugated E3 levels between the two groups. Although birth weights were higher in pregnant women ≥41 weeks, this difference was not considered significant (p=0.19). There were no SGA babies in the group of post-term pregnancies.
CONCLUSION: There were no statistically significant differences in maternal serum markers for pregnant women having their period of ≥41 gestational week.

Downloads

Download data is not yet available.

Downloads

Published

2011-08-09

How to Cite

1.
Kansu Çelik H, Engin Üstün Y, Timur H, Yaman S, Yılmaz S, Yapar Eyı EG, Mollamahmutoğlu L. Evaluation of Antenatal Maternal Serum Biomarkers in Pregnancies Over 41 Weeks. Gynecol Obstet Reprod Med [Internet]. 2011Aug.9 [cited 2024Nov.22];17(2):72-5. Available from: https://gorm.com.tr/index.php/GORM/article/view/294

Issue

Vol. 17 No. 2 (2011)

Section

Obstetrics; Maternal Fetal Medicine and Perinatology

License

CC BY

All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.